CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 58 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $963,914 | -15.4% | 160,385 | -18.1% | 0.00% | -25.0% |
| Q3 2022 | $1,139,000 | -86.4% | 195,749 | -86.0% | 0.00% | -85.7% |
| Q2 2022 | $8,354,000 | -1.7% | 1,399,372 | -23.1% | 0.03% | +12.0% |
| Q1 2022 | $8,495,000 | +867.5% | 1,818,962 | +413.5% | 0.02% | +1150.0% |
| Q4 2021 | $878,000 | -72.2% | 354,218 | -66.9% | 0.00% | -71.4% |
| Q3 2021 | $3,154,000 | -0.8% | 1,069,243 | -15.9% | 0.01% | 0.0% |
| Q2 2021 | $3,180,000 | +56.3% | 1,271,819 | +82.0% | 0.01% | +40.0% |
| Q1 2021 | $2,034,000 | +52.1% | 698,912 | +68.4% | 0.01% | +25.0% |
| Q4 2020 | $1,337,000 | +253.7% | 415,154 | +136.3% | 0.00% | +300.0% |
| Q3 2020 | $378,000 | +779.1% | 175,680 | +368.6% | 0.00% | – |
| Q2 2020 | $43,000 | +19.4% | 37,492 | -4.1% | 0.00% | – |
| Q1 2020 | $36,000 | -67.6% | 39,092 | -44.1% | 0.00% | – |
| Q4 2019 | $111,000 | +23.3% | 69,953 | -34.9% | 0.00% | – |
| Q3 2019 | $90,000 | -19.6% | 107,456 | -17.2% | 0.00% | – |
| Q2 2019 | $112,000 | -34.1% | 129,812 | -25.9% | 0.00% | -100.0% |
| Q1 2019 | $170,000 | +5.6% | 175,114 | -20.2% | 0.00% | 0.0% |
| Q4 2018 | $161,000 | -64.3% | 219,569 | +5.2% | 0.00% | 0.0% |
| Q3 2018 | $451,000 | -40.4% | 208,810 | +37.4% | 0.00% | -50.0% |
| Q2 2018 | $757,000 | +141.9% | 151,969 | +89.3% | 0.00% | +100.0% |
| Q1 2018 | $313,000 | – | 80,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 6,535,674 | $27,449,831 | 9.21% |
| Bleichroeder LP | 3,893,730 | $16,353,666 | 3.49% |
| AIGH Capital Management LLC | 2,100,000 | $8,820,000 | 3.25% |
| Ally Bridge Group (NY) LLC | 550,000 | $2,310,000 | 3.03% |
| Ghost Tree Capital, LLC | 2,000,000 | $8,400,000 | 2.48% |
| Bain Capital Life Sciences Investors, LLC | 4,702,996 | $19,753 | 2.47% |
| Altium Capital Management LP | 850,000 | $3,570,000 | 1.98% |
| Parkman Healthcare Partners LLC | 1,753,630 | $7,365,246 | 1.60% |
| BVF INC/IL | 8,813,021 | $37,014,688 | 1.35% |
| Sio Capital Management, LLC | 526,239 | $2,210,204 | 1.09% |